BIBLIOS

  Ciências References Management System

Visitor Mode (Login)
Need help?


Back

Publication details

Document type
Journal articles

Document subtype
Full paper

Title
Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view

Participants in the publication
K. De Boeck (Author)
T. Lee (Author)
M. Amaral (Author)
Dep. Química e Bioquímica
BIOISI - Instituto de Biossistemas e Ciências Integrativas
P. Drevinek (Author)
J.S. Elborn (Author)
I. Fajac (Author)
E. Kerem (Author)
J.C. Davies (Author)

Date of Publication
2020-09

Where published
Journal of Cystic Fibrosis

Publication Identifiers
ISSN - 1569-1993

Publisher
Elsevier BV

Volume
19
Number
5

Number of pages
7
Starting page
688
Last page
695

Document Identifiers
DOI - https://doi.org/10.1016/j.jcf.2020.05.012
URL - http://dx.doi.org/10.1016/j.jcf.2020.05.012

Rankings
Web Of Science 4.759 (2019) - Q1 - RESPIRATORY SYSTEM - SCIE
SCOPUS Q1 (2019) - 6.6 - Pediatrics, Perinatology and Child Health
SCOPUS Q1 (2019) - 6.6 - Pulmonary and Respiratory Medicine
SCIMAGO Q1 (2019) - 1.411 - Pulmonary and Respiratory Medicine
SCIMAGO Q1 (2019) - 1.411 - Pediatrics, Perinatology and Child Health


Export

APA
K. De Boeck, T. Lee, M. Amaral, P. Drevinek, J.S. Elborn, I. Fajac, E. Kerem, J.C. Davies, (2020). Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view. Journal of Cystic Fibrosis, 19, 688-695. ISSN 1569-1993. eISSN . http://dx.doi.org/10.1016/j.jcf.2020.05.012

IEEE
K. De Boeck, T. Lee, M. Amaral, P. Drevinek, J.S. Elborn, I. Fajac, E. Kerem, J.C. Davies, "Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view" in Journal of Cystic Fibrosis, vol. 19, pp. 688-695, 2020. 10.1016/j.jcf.2020.05.012

BIBTEX
@article{49484, author = {K. De Boeck and T. Lee and M. Amaral and P. Drevinek and J.S. Elborn and I. Fajac and E. Kerem and J.C. Davies}, title = {Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view}, journal = {Journal of Cystic Fibrosis}, year = 2020, pages = {688-695}, volume = 19 }